Kirin expands LC-Plasma postbiotic into everyday beverages, targeting mainstream health

Tokyo, Japan — 07 August 2026

Kirin Holdings is strategically integrating its proprietary LC-Plasma postbiotic into conventional beverage and foodservice channels, signalling a broader industry pivot towards embedding functional health benefits into daily consumption patterns. LC-Plasma, derived from Lactococcus lactis strain Plasma, is designed to support immune function. This expansion occurs as Kirin Beverage confronts significant commercial headwinds, including a 2.8% year-over-year revenue decline to ¥121.8 billion (US$769 million) and a sharp 30.2% drop in normalized operating profit to ¥5.2 billion (US$32.8 million) in the first half of 2026, according to company reports. These financial pressures stem from reduced sales volumes, escalating raw material and processing costs, and increased marketing expenditure, some of which supported new LC-Plasma product launches like the iMUSE Fruit Refresh range.

The iMUSE Fruit Refresh line, featuring 500 mL PET beverages combining LC-Plasma with fruit flavours and vitamins, exemplifies Kirin’s strategy to move immune support beyond niche wellness segments into the mainstream soft drink market. Launched in April, these products position functionality as an intrinsic part of refreshment and taste, rather than solely a health proposition. Kirin’s Senior Executive Officer, Mitsuharu Yamagata, noted in the company’s 2026 Integrated Report that the efficacy of such technology hinges on its seamless integration into consumers' daily routines. Early sales metrics validate this approach, with over 10 million bottles sold within three weeks of launch and iMUSE brand volumes up approximately 70% in April year-on-year. This success underscores a market appetite for functional ingredients delivered via established consumption habits, reducing the need for separate supplement routines.

Beyond traditional retail, Kirin is extending LC-Plasma's reach into institutional foodservice with products like Kirin Tsuyoi zo! Mutekids, a children's beverage, and expanding internationally. In Vietnam, its subsidiary Interfood relaunched iMUSE in June as a 430 mL lemon-and-yogurt refreshment drink, distributing it across supermarkets, convenience stores, and institutional settings. This multi-channel and multi-geography approach highlights Kirin’s commitment to leveraging high-value ingredients as a core growth driver for its Health Science business. The company targets ¥30-33 billion (US$189-208 million) in normalized operating profit from this division by 2030 through organic growth, with ambitions for ¥500 billion (US$3.16 billion) in revenue by 2035, including acquisitions. The Health Science segment already saw a 20.8% year-over-year rise in normalized operating profit to ¥10.4 billion (US$65.6 million) in H1.

What this means for Japan

Japanese brand owners and manufacturers must recognise the commercial imperative behind Kirin's strategy: mainstreaming functional ingredients to offset margin pressure from traditional portfolios. Reformulation windows for new product development need to prioritise familiar formats with embedded health benefits, targeting broader consumer bases. Procurement leads should assess the long-term supply chain resilience of core ingredients, as Kirin's SBTN validation identified water and land risks in tea sourcing, particularly from Sri Lanka, impacting the Gogo-no-Kocha brand. This necessitates diversifying sourcing or investing in sustainable practices to mitigate future supply disruptions and cost volatility. Competitive positioning requires developing innovative delivery systems that simplify functional consumption without relying on overt health claims alone.

Kirin also completed validation for Steps 1 and 2 of the Science Based Targets Network framework, becoming the first Asia-Pacific company to report on the SBTN Target Tracker. This assessment addressed water usage and pollution within its operations and evaluated nature-related risks in upstream commodity supply chains, including water, soil, and land use. Sri Lanka, a critical sourcing region for tea leaves used in Kirin’s Gogo-no-Kocha bottled tea, was identified as a priority area for water and land management. While Kirin pursues growth through high-value ingredients, managing the sustainability and resilience of its core agricultural supply chains remains a parallel strategic imperative, contributing to a revised full-year normalized operating profit forecast increase to ¥253 billion (US$1.60 billion).

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.